Jiangsu Kanion Pharmaceutical Co Ltd (600557) — Capital Reinvestment Ratio
Jiangsu Kanion Pharmaceutical Co Ltd (600557) has a Capital Reinvestment Ratio of 0.64x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥201.83 Million) in capital expenditures (CN¥128.94 Million). Check 600557 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Jiangsu Kanion Pharmaceutical Co Ltd Capital Reinvestment Ratio (2001–2024)
This chart tracks Jiangsu Kanion Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 23 annual periods. For the full cash flow conversion analysis, see 600557 cash flow conversion.
Annual Capital Reinvestment Ratio for Jiangsu Kanion Pharmaceutical Co Ltd (2001–2024)
Year-by-year Capital Reinvestment Ratio for Jiangsu Kanion Pharmaceutical Co Ltd from 2001 to 2024. See Jiangsu Kanion Pharmaceutical Co Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.68x | CN¥702.49 Million | CN¥476.69 Million | ▲ +121.8% |
| 2023 | 0.31x | CN¥972.32 Million | CN¥297.48 Million | ▲ +44.4% |
| 2022 | 0.21x | CN¥995.94 Million | CN¥211.09 Million | ▲ +12.2% |
| 2021 | 0.19x | CN¥908.30 Million | CN¥171.52 Million | ▼ -30.4% |
| 2020 | 0.27x | CN¥701.10 Million | CN¥190.32 Million | ▼ -48.7% |
| 2019 | 0.53x | CN¥925.73 Million | CN¥490.06 Million | ▲ +6.7% |
| 2018 | 0.50x | CN¥636.39 Million | CN¥315.73 Million | ▼ -27.2% |
| 2017 | 0.68x | CN¥382.93 Million | CN¥260.94 Million | ▼ -37.4% |
| 2016 | 1.09x | CN¥299.02 Million | CN¥325.24 Million | ▲ +49.4% |
| 2015 | 0.73x | CN¥514.80 Million | CN¥374.80 Million | ▼ -26.7% |
| 2014 | 0.99x | CN¥311.54 Million | CN¥309.36 Million | ▲ +13.6% |
| 2013 | 0.87x | CN¥388.11 Million | CN¥339.23 Million | ▼ -27.0% |
| 2012 | 1.20x | CN¥212.11 Million | CN¥253.88 Million | ▼ -63.2% |
| 2011 | 3.25x | CN¥90.19 Million | CN¥293.53 Million | ▲ +90.1% |
| 2010 | 1.71x | CN¥166.40 Million | CN¥284.89 Million | ▲ +15.3% |
| 2008 | 1.48x | CN¥58.39 Million | CN¥86.69 Million | ▲ +133.8% |
| 2007 | 0.63x | CN¥92.73 Million | CN¥58.88 Million | ▲ +182.2% |
| 2006 | 0.22x | CN¥108.98 Million | CN¥24.52 Million | ▼ -57.3% |
| 2005 | 0.53x | CN¥101.44 Million | CN¥53.39 Million | ▼ -90.7% |
| 2004 | 5.66x | CN¥21.68 Million | CN¥122.68 Million | ▼ -23.5% |
| 2003 | 7.40x | CN¥17.13 Million | CN¥126.72 Million | ▼ -6.3% |
| 2002 | 7.90x | CN¥11.15 Million | CN¥88.07 Million | ▲ +800.5% |
| 2001 | 0.88x | CN¥21.02 Million | CN¥18.43 Million | — |